Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:29 pm Sale | 2024-09-30 | 13G | Oragenics, Inc. OGEN | Lind Global Fund II LP | 0 0.000% | -8,833 (Position Closed) | Filing History |
| 2024-11-14 7:29 pm Unchanged | 2024-09-30 | 13G | ToughBuilt Industries, Inc. TBLT | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 7:28 pm Purchase | 2024-09-30 | 13G | Siyata Mobile Inc. SYTA | Lind Global Fund II LP | 63 0.000% | 63 (New Position) | Filing History |
| 2024-11-14 7:28 pm Purchase | 2024-09-30 | 13G | SenesTech, Inc. SNES | Lind Global Fund II LP | 92,500 9.900% | 92,500 (New Position) | Filing History |
| 2024-11-14 7:27 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 103,530 8.100% | 103,530 (New Position) | Filing History |
| 2024-11-14 7:25 pm Purchase | 2024-09-30 | 13G | Sintx Technologies, Inc. SINT | Lind Global Fund II LP | 71,500 5.100% | 71,500 (New Position) | Filing History |
| 2024-11-14 7:25 pm Purchase | 2024-09-30 | 13G | Netcapital Inc. NCPL | Lind Global Fund II LP | 119,000 9.900% | 119,000 (New Position) | Filing History |
| 2024-11-14 7:24 pm Purchase | 2024-09-30 | 13G | Edible Garden AG Incorporated EDBL | Lind Global Fund II LP | 1,430 0.200% | 1,430 (New Position) | Filing History |
| 2024-11-14 7:23 pm Purchase | 2024-09-30 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Lind Global Fund II LP | 3,125 1.200% | 3,125 (New Position) | Filing History |
| 2024-11-14 7:22 pm Purchase | 2024-09-30 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 1,008,599 8.800% | 756,829 (+300.60%) | Filing History |
| 2024-11-14 7:21 pm Sale | 2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Lind Global Fund II LP | 0 0.000% | -426 (Position Closed) | Filing History |
| 2024-11-14 7:21 pm Purchase | 2024-09-30 | 13G | Cingulate Inc. CING | Lind Global Fund II LP | 98,918 3.100% | 98,918 (New Position) | Filing History |
| 2024-11-14 7:20 pm Sale | 2024-09-30 | 13G | BIOLASE INC PAR $.001 BIOLQ | Lind Global Fund II LP | 0 0.000% | -1,190,000 (Position Closed) | Filing History |
| 2024-11-14 7:19 pm Unchanged | 2024-09-30 | 13G | Bone Biologics Corporation BBLG | Lind Global Fund II LP | 5,697 1.900% | 0 (Unchanged) | Filing History |
| 2024-11-14 7:18 pm Sale | 2024-09-30 | 13G | Mobiquity Technologies, Inc. MOBQ | Lind Global Fund II LP | 122,695 0.800% | -282,305 (-69.70%) | Filing History |
| 2024-11-14 7:17 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 109,160 3.500% | 109,160 (New Position) | Filing History |
| 2024-11-14 7:16 pm Purchase | 2024-09-30 | 13G | Intelligent Bio Solutions Inc. INBS | Lind Global Fund II LP | 151,515 3.400% | 151,515 (New Position) | Filing History |
| 2024-11-14 7:15 pm Purchase | 2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT | Lind Global Fund II LP | 322 0.400% | 322 (New Position) | Filing History |
| 2024-11-14 7:15 pm Sale | 2024-09-30 | 13G | ASLAN Pharmaceuticals Limited ASLN | Lind Global Fund II LP | 0 0.000% | -156,250 (Position Closed) | Filing History |
| 2024-11-14 7:14 pm Purchase | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Lind Global Fund II LP | 375,000 9.900% | 375,000 (New Position) | Filing History |